Pacs Group Inc. (PACS)
NYSE NYSE Primary 
Wall Street Analysts Think PACS Group, Inc. (PACS) Could Surge 30.96%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 31% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PACS or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either PACS Group, Inc. (PACS) or Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Wall Street Analysts Believe PACS Group, Inc. (PACS) Could Rally 31.15%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PACS vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
PACS or MEDP: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
PACS Group, Inc. (PACS) Upgraded to Strong Buy: Here's Why
PACS Group, Inc. (PACS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PACS vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect?
The consensus price target hints at a 25.5% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Best Value Stock to Buy for March 5th
PACS made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 5, 2026.
PACS Group, Inc. (PACS) Q4 2025 Earnings Call Transcript
PACS Group, Inc. (PACS) Q4 2025 Earnings Call Transcript
PACS Group, Inc. (PACS) Misses Q4 Earnings Estimates
PACS Group, Inc. (PACS) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.25 per share a year ago.
Why One Fund Bought 1 Million Shares of This Healthcare Provider Stock Up 185% This Past Year
Utah-based Crewe Advisors bought 1,035,747 PACS shares in the fourth quarter for an estimated $22.72 million. Meanwhile, the quarter-end PACS position value rose by $67.19 million, reflecting both trading and stock price changes.
